Product Information
LOSARTAN POTASSIUM 50 MG TAB is a generic product labeled by Quallent Pharmaceuticals Health LLC, priced at $0.0327 per EA under NDC 82009004310. Its NADAC has been published 200 times since Dec 7, 2022.
FDA first approved this application on Oct 6, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/1
Manufacturer
Quallent Pharmaceuticals Health LLCNDC
82009004310
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LOSARTAN POTASSIUMApproval Type
Generic (ANDA)
FDA Application
ANDA078243FDA Approved
10/6/2010
TE Code
AB
On Market Since
9/20/2022
Pharmacological Classes
Price Statistics
The NADAC for LOSARTAN POTASSIUM 50 MG TAB has been published 200 times since Dec 7, 2022, and over the history we have for it it has declined 37.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0327 per EA |
|---|---|
| All-time high | $0.0545 (Jan 11, 2023) |
| All-time low | $0.0304 (Nov 19, 2025) |
| 52-week high | $0.0343 |
| 52-week low | $0.0304 |
| Median price | $0.0380 |
| Average price | $0.0392 |
| Largest weekly change | -23.1% (Nov 20, 2024) |
| Weeks tracked | 200 |
| Tracking since | Dec 7, 2022 |
Generic Alternatives
The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Quallent Pharmaceuticals Health LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Losartan Potassium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Angiotensin 2 Receptor Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LOSARTAN POTASSIUM 50 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for LOSARTAN POTASSIUM 50 MG TAB, manufactured by Quallent Pharmaceuticals Health LLC, is $0.0327 per EA (NDC 82009004310), effective Sep 30, 2026.
How has the price of LOSARTAN POTASSIUM 50 MG TAB changed over time?
Over the history we have for it, the NADAC for LOSARTAN POTASSIUM 50 MG TAB has declined 37.8%. It has been tracked across 200 weekly CMS publications since Dec 7, 2022.
What are the highest and lowest recorded NADAC prices for LOSARTAN POTASSIUM 50 MG TAB?
Since Dec 7, 2022, the NADAC for LOSARTAN POTASSIUM 50 MG TAB has ranged from a low of $0.0304 (Nov 19, 2025) to a high of $0.0545 (Jan 11, 2023), with a median of $0.0380 per EA.
Are there cheaper alternatives to LOSARTAN POTASSIUM 50 MG TAB?
Yes. 10 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LOSARTAN POTASSIUM 50 MG TAB, is $0.0315 per EA — about 4% below LOSARTAN POTASSIUM 50 MG TAB.
Who manufactures LOSARTAN POTASSIUM 50 MG TAB?
LOSARTAN POTASSIUM 50 MG TAB (NDC 82009004310) is labeled by Quallent Pharmaceuticals Health LLC, and CMS classifies it as a generic product.